Clinical Outcomes of Osteonecrosis of the Femoral Head After Autologous Bone Marrow Stem Cell Implantation: a Meta-analysis of Seven Case-control Studies

Overview

Journal Clinics (Sao Paulo)

Publisher Elsevier

Specialty General Medicine

Date 2016 Mar 3

PMID 26934241

Citations 14

Authors

Heng-Feng Yuan

Jing Zhang

Chang-An Guo

Zuo-Qin Yan

Affiliations

Soon will be listed here.

Abstract

The purpose of this study was to evaluate the clinical outcomes of osteonecrosis of the femoral head after autologous bone marrow stem cell implantation. We searched the PubMed, Embase and Web of Science databases and included all case-control trials that reported on the clinical outcomes of osteonecrosis progression, incidence of total hip arthroplasty and improvement in Harris hip scores. Overall, seven case-control trials were included. Compared with the controls, patients treated with the bone marrow stem cells implantation treatment showed improved clinical outcomes with delayed osteonecrosis progression (odds ratio = 0.17, 95% CI: 0.09 - 0.32; p <0.001), a lower total hip arthroplasty incidence (odds ratio = 0.30, 95% CI: 0.12 - 0.72; p <0.01) and increased Harris hip scores (mean difference = 4.76, 95% CI: 1.24 - 8.28; p<0.01). The heterogeneity, publication bias, and sensitivity analyses showed no statistical difference significant differences between studies. Thus, our study suggests that autologous bone marrow stem cells implantation has a good therapeutic effect on osteonecrosis of the femoral, resulting in beneficial clinical outcomes. However, trials with larger sample sizes are needed to confirm these findings.

Citing Articles

Comparing the efficacy of 3D-printing-assisted surgery with traditional surgical treatment of fracture: an umbrella review.

Xiao L, Tang P, Yang S, Su J, Ma W, Tan H J Orthop Traumatol. 2025; 26(1):3.

PMID: 39843654 PMC: 11754758. DOI: 10.1186/s10195-025-00819-0.

Etiology, pathology, and treatment of osteonecrosis of the femoral head in adolescents: A comprehensive review.

Lou Y, Wu J, Zhong Y, Tong P, Du W Medicine (Baltimore). 2024; 103(30):e39102.

PMID: 39058826 PMC: 11272257. DOI: 10.1097/MD.0000000000039102.

The pandemic is gone but its consequences are here to stay: avascular necrosis following corticosteroids administration for severe COVID-19.

Migliorini F, Maffulli N, Shukla T, DAmbrosi R, Singla M, Vaish A J Orthop Surg Res. 2024; 19(1):135.

PMID: 38347592 PMC: 10860242. DOI: 10.1186/s13018-024-04556-8.

tsRNA-15797-modified BMSC-derived exosomes mediate LFNG to induce angiogenesis in osteonecrosis of the femoral head.

Fang S, You M, Wei J, Chen P Turk J Biol. 2023; 47(3):186-198.

PMID: 37529417 PMC: 10388130. DOI: 10.55730/1300-0152.2654.

Osteonecrosis of the Femoral Head. Optimizing the Early-Stage Joint-Preserving Surgical Treatment?.

Karampinas P, Galanis A, Papagrigorakis E, Vavourakis M, Vlachos C, Zachariou D Maedica (Bucur). 2023; 17(4):948-954.

PMID: 36818255 PMC: 9923054. DOI: 10.26574/maedica.2022.17.4.948.

References

Conway E, Collen D, Carmeliet P . Molecular mechanisms of blood vessel growth. Cardiovasc Res. 2001; 49(3):507-21. DOI: 10.1016/s0008-6363(00)00281-9. View

Chang C, Greenspan A, Gershwin M . Osteonecrosis: current perspectives on pathogenesis and treatment. Semin Arthritis Rheum. 1993; 23(1):47-69. DOI: 10.1016/s0049-0172(05)80026-5. View

Bianco P, Riminucci M, Gronthos S, Robey P . Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells. 2001; 19(3):180-92. DOI: 10.1634/stemcells.19-3-180. View

Gangji V, Hauzeur J, Schoutens A, Hinsenkamp M, Appelboom T, Egrise D . Abnormalities in the replicative capacity of osteoblastic cells in the proximal femur of patients with osteonecrosis of the femoral head. J Rheumatol. 2003; 30(2):348-51. View

Johnson E, Soultanis K, Soucacos P . Vascular anatomy and microcirculation of skeletal zones vulnerable to osteonecrosis: vascularization of the femoral head. Orthop Clin North Am. 2004; 35(3):285-91, viii. DOI: 10.1016/j.ocl.2004.03.002. View

HERNDON J, AUFRANC O . Avascular necrosis of the femoral head in the adult. A review of its incidence in a variety of conditions. Clin Orthop Relat Res. 1972; 86:43-62. DOI: 10.1097/00003086-197207000-00008. View

Mont M, Hungerford D . Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am. 1995; 77(3):459-74. DOI: 10.2106/00004623-199503000-00018. View

Mankin H . Nontraumatic necrosis of bone (osteonecrosis). N Engl J Med. 1992; 326(22):1473-9. DOI: 10.1056/NEJM199205283262206. View

Yamamoto T, Irisa T, Sugioka Y, Sueishi K . Effects of pulse methylprednisolone on bone and marrow tissues: corticosteroid-induced osteonecrosis in rabbits. Arthritis Rheum. 1997; 40(11):2055-64. DOI: 10.1002/art.1780401119. View

10.

Hernigou P, Poignard A, Nogier A, Manicom O . Fate of very small asymptomatic stage-I osteonecrotic lesions of the hip. J Bone Joint Surg Am. 2004; 86(12):2589-93. DOI: 10.2106/00004623-200412000-00001. View

11.

Bejar J, Peled E, Boss J . Vasculature deprivation--induced osteonecrosis of the rat femoral head as a model for therapeutic trials. Theor Biol Med Model. 2005; 2:24. PMC: 1208957. DOI: 10.1186/1742-4682-2-24. View

12.

Yan Z, Hang D, Guo C, Chen Z . Fate of mesenchymal stem cells transplanted to osteonecrosis of femoral head. J Orthop Res. 2008; 27(4):442-6. DOI: 10.1002/jor.20759. View

13.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

14.

Yamasaki T, Yasunaga Y, Ishikawa M, Hamaki T, Ochi M . Bone-marrow-derived mononuclear cells with a porous hydroxyapatite scaffold for the treatment of osteonecrosis of the femoral head: a preliminary study. J Bone Joint Surg Br. 2010; 92(3):337-41. DOI: 10.1302/0301-620X.92B3.22483. View

15.

Chang T, Tang K, Tao X, Cao H, Li H, Chen Q . [Treatment of early avascular necrosis of femoral head by core decompression combined with autologous bone marrow mesenchymal stem cells transplantation]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2010; 24(6):739-43. View

16.

Gangji V, De Maertelaer V, Hauzeur J . Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: Five year follow-up of a prospective controlled study. Bone. 2011; 49(5):1005-9. DOI: 10.1016/j.bone.2011.07.032. View

17.

Zhao D, Cui D, Wang B, Tian F, Guo L, Yang L . Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells. Bone. 2011; 50(1):325-30. DOI: 10.1016/j.bone.2011.11.002. View

18.

Sen R, Tripathy S, Aggarwal S, Marwaha N, Sharma R, Khandelwal N . Early results of core decompression and autologous bone marrow mononuclear cells instillation in femoral head osteonecrosis: a randomized control study. J Arthroplasty. 2011; 27(5):679-86. DOI: 10.1016/j.arth.2011.08.008. View

19.

Liu Y, Liu S, Su X . Core decompression and implantation of bone marrow mononuclear cells with porous hydroxylapatite composite filler for the treatment of osteonecrosis of the femoral head. Arch Orthop Trauma Surg. 2012; 133(1):125-33. DOI: 10.1007/s00402-012-1623-3. View

20.

Murphy M, Moncivais K, Caplan A . Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med. 2013; 45:e54. PMC: 3849579. DOI: 10.1038/emm.2013.94. View